A regional hospital plans to expand the use of continuous intravenous insulin infusions to its intermediate care medical wards, a practice that was previously restricted to the intensive care unit. Given the high-risk nature of intravenous insulin, the chief quality officer convenes a multidisciplinary team before the new policy is implemented. The team systematically maps out the proposed new workflow, from the initial physician order to nurse administration and blood glucose monitoring. At each step, they brainstorm how the process might fail, evaluate the potential clinical consequences of such a failure, and calculate a risk priority number. This analysis is then used to design safety constraints prior to the program's official launch. Which of the following best describes the methodology this team is utilizing?
- Failure mode and effects analysisAnswer
- BRoot cause analysis
- CPlan-Do-Study-Act cycle
- DIshikawa (fishbone) diagram
- EStandardized handoff protocol